6-29659619-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_206809.4(MOG):c.389G>A(p.Arg130Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000701 in 1,613,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_206809.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOG | NM_206809.4 | c.389G>A | p.Arg130Gln | missense_variant | 2/8 | ENST00000376917.8 | NP_996532.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOG | ENST00000376917.8 | c.389G>A | p.Arg130Gln | missense_variant | 2/8 | 1 | NM_206809.4 | ENSP00000366115 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000976 AC: 24AN: 245892Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134084
GnomAD4 exome AF: 0.0000671 AC: 98AN: 1460814Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 726716
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.389G>A (p.R130Q) alteration is located in exon 2 (coding exon 2) of the MOG gene. This alteration results from a G to A substitution at nucleotide position 389, causing the arginine (R) at amino acid position 130 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at